GH Research Stock Quote GHRS - Stock Price, News, Charts, Message Board, Trades

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
GH Research PLC (GHRS) Quote

GH Research PLC (GHRS)

13.28

0.68

(5.40%)

Closed May 21 4:00PM

Delayed by 15 minutes

12.8872

-0.3928

(-2.96%)

After Hours: 7:59PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

13.28

Bid

12.93

Ask

13.50

Volume

43,934

12.52 Day's Range 13.41

5.05 52 Week Range 14.70

Market Cap

Previous Close

12.60

Open

12.63

Last Trade

Last Trade Time

Financial Volume

$ 570,452

VWAP

12.9843

Average Volume (3m)

95,856

Shares Outstanding

52,028,145

Dividend Yield

-

PE Ratio

-19.44

Earnings Per Share (EPS)

-0.68

Revenue

-

Net Profit

-35.59M

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ghres.com

Headquarters

Dublin, Irl

Founded

1970

GH Research PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GHRS. The last closing price for GH Research was $12.60. Over the last year, GH Research shares have traded in a share price range of $ 5.05 to $ 14.70.

GH Research currently has 52,028,145 shares outstanding. The market capitalization of GH Research is $691.97 million. GH Research has a price to earnings ratio (PE ratio) of -19.44.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

GH Research Reports Full Year 2023 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024Phase 2a clinical trial of GH001 in postpartum...

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.37	2.86599535244	12.91	13.41	12.3	41031	12.81490488	CS
4	2.11	18.8898836168	11.17	13.41	10.3	53706	11.86394422	CS
12	5.78	77.0666666667	7.5	13.41	6.82	95856	10.72460465	CS
26	6.88	107.5	6.4	13.41	5.05	106116	8.42177458	CS
52	2.19	19.7475202885	11.09	14.7	5.05	92123	9.33687698	CS
156	-8.72	-39.6363636364	22	30.43	5.05	87209	13.84253974	CS
260	-8.72	-39.6363636364	22	30.43	5.05	87209	13.84253974	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GTBPGT Biopharma Inc	$ 7.75 (148.40%)	64.96M
MMVMultiMetaVerse Holdings Ltd	$ 1.33 (125.12%)	129.91M
PEGYPineapple Energy Inc	$ 0.19 (80.27%)	369.22M
FFIEFaraday Future Intelligent Electric Inc	$ 1.80 (74.76%)	701.56M
ZENVZenvia Inc	$ 3.82 (66.09%)	647.37k
MTCMMTec Inc	$ 1.0305 (-85.30%)	70.48M
AKTSAkoustis Technologies Inc	$ 0.158 (-55.64%)	24.69M
FLJFLJ Group Limited	$ 0.7701 (-50.32%)	4.8M
VIRIVirios Therapeutics Inc	$ 0.2049 (-41.69%)	5.5M
JFBRJeffs Brands Ltd	$ 0.395 (-39.04%)	6.6M
CRKNCrown Electrokinetics Corporation	$ 0.1958 (14.50%)	751.67M
FFIEFaraday Future Intelligent Electric Inc	$ 1.80 (74.76%)	701.56M
GWAVGreenwave Technology Solutions Inc	$ 0.1584 (2.79%)	656.05M
PEGYPineapple Energy Inc	$ 0.19 (80.27%)	369.22M
BRSHBruush Oral Care Inc	$ 0.158 (34.81%)	259.84M

hyperopia

hyperopia 6 minutes ago

bio, the poster that you responded to was ae kusterer, who we all know, reposts other people posts without good reference. It was my post that he reposted, which I also put in my response to you as reference. You basically claimed in your response to him that part of my theory, which states that p

BDEZ

BDEZ 6 minutes ago

DPLS trending on thelion.com

dinogreeves

dinogreeves 7 minutes ago

"he told us in 2020 he would regulate oil out of existence."

For that statement alone he will not be reelected. Here is simple fact, when you read the headlines in the papers or news, as simple as this is Hertz reselling their inventory of over 100,000 Tesla in the second hand marke

PeterP1

PeterP1 9 minutes ago

It's simple, Cloudsmartz build for any telco or MSP, nothing unique to Contrivian. https://decathloncapital.com/2023/01/17/cloudsmartz-lands-growth-funding-from-decathlon-capital-partners/ OneMind NG is separate to Contrivian.

satter

satter 9 minutes ago

How much time are you calling on to tell here?

No comment on the annual report? Not a surprise. No comment from anyone. It's so telling how the business has been destroyed yet Eric pumped, hyped, how things were so promising, so much potential. Complete mispresentation and he still

Xl175

Xl175 11 minutes ago

Imagine this: Jamie Dimon jumping ship soon. Why?

DMC8

DMC8 16 minutes ago

Discordance Among ApoB, non–HDL-C, and Triglycerides for CV Prevention
May 20, 2024

https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2024/05/20/03/46/discordance-among-apob

mc73

mc73 17 minutes ago

For the record I saw this post, looked at the post Tiger responded to, and replied to that post. Funny thing is I had replied to the OP and basically said the same thing I said today.

I will not reply on this topic further...u guys all get so butt hurt. Gheeze

xyz1002

xyz1002 21 minutes ago

$GGEI - 100X Potential - Read Below
Nasdaq Delisted Play
China Property Developer
Total Assets Near $1.5O/Share
Total Equity Near $0.15/Share
OS= 154.7 Million
Insiders have bought a ton @ $0.17

littlejohn

littlejohn 21 minutes ago

SDOW, SQQQ...institutions have the largest

holdings in companies by far over

the retail movers or holders...

Retail traders play to position or profit

of earnings or other events...

Institutions tend to hold and will use thin

Xl175

Xl175 22 minutes ago

I am not here to preach about politics, but why invest your money here if you vote democrat? It’s like apples vs paper. The two don’t even compare.

uber darthium

uber darthium 23 minutes ago

I don’t know who the Gandhi guy is next to her. Does she look like she has had a facelift since you last saw her in person or has she always looked like that ? She looks like a blonde hair version of Kenny Rogers face after his botched surgeries

RichieBoy

RichieBoy 26 minutes ago

That raised my eyebrows too

But what about CloudSmartz 🤔

xyz1002

xyz1002 27 minutes ago

Cash $ 4,754,893
Restricted cash 2,489,086
Contract assets 7,087,856
Real estate property development completed 74,013,771
Inventory 7,272
Other assets 1,839,933
Prepayment 26,936,915
Property, plant and equipment, net 456,22

Xl175

Xl175 27 minutes ago

That is a huge backtrack that this administration has not made. If they remain in power, they will kill American lng exports. Biden has been honest in this regard, he told us in 2020 he would regulate oil out of existence.

ducci1

ducci1 28 minutes ago

Chart Chat: ES 30 min---Rising Wedge ---Bottom --Rising Channel T/L----Upper T/L----5333--Again--Line in the Sand!

Sunman88

Sunman88 28 minutes ago

Stockedandloaded on stocktwits: Per Iova’s clinical updates in January of last year, Cohort 1A was qualitatively updated to (n) of 20.
“Updated results from nearly 20 patients treated in Cohort 1A of the IOV-COM-202 trial of lifileucel in combination with pembrolizumab in frontline advanced

Bob Mullet

Bob Mullet 30 minutes ago

Talking about being full of crap…

Where will they store all the silk?

Isn’t the disused shed at Warwick mills full already??!?

Wise Man

Wise Man 31 minutes ago

THE SEPARATE ACCOUNT PLAN WAS PURSUED DELIBERATELY.
Not just the very moment that Calabria and Pelosi with HERA enacted a homonymous second UST backup of FnF, inserting it in the Charter Act just below the original one, without including it as an exception to the Fee Limitation of the United

ron_66271

ron_66271 31 minutes ago

We Released the 2008 JPM BOD Personal Only.

41.6 Release is specific to the JPM executives involved in Project West illegal undermining and collusion with the FDIC for the seizure of WMB. Not any future JPM executives.

Yes; WMI sued the FDIC for $307.2 Billion. The FDIC

RichieBoy

RichieBoy 34 minutes ago

Supplemental to this 👆 previous post
NorthStar®️ is owned by Contrivian. Not sure why or how I got OneMind NG mixed into the bunch but that's what I get for DD @ 2 in the morning...

Soes yah know.

Matrix999

Matrix999 42 minutes ago

For a great tic toc video to win an award

Before we used plywood we built in corner braces

They had neither

arizona1

arizona1 43 minutes ago

Those twitter kids!

sentiment_stocks

sentiment_stocks 44 minutes ago

I didn’t forget it… but thanks for the reminder. :)

Jpmorgan Chase Bank Na C...

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions